Egypt: IDH expands investor base with dual-listed shares on the Egyptian Exchange
The Egyptian pound-denominated, dual-listed shares in Integrated Diagnostics Holdings (IDH), a London-listed consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, began trading on the Egyptian Exchange last week. There was no concurrent offering of new shares. The technical listing allows Egypt-based investors to trade in IDH’s shares, using exposure to the company…
You must be a HMI Subscriber to view this content.
Nick Herbert has over 30 years’ experience in the financial markets, as both a practitioner and journalist. He started work as an investment banker in London, before joining International Financing Review (IFR) to report on debt capital markets and derivatives. He moved to Singapore in 2000 to manage IFR’s financial markets editorial team throughout Asia, before returning to London in 2009 to take up the position of Publisher for Reuters Capital Market
TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry
Tue, 25th May 2021 19:40
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Bank of Cyprus Holdings PLC - Strovolos, Cyprus-headquartered financial services firm - Reports total income of EUR136 million in first quarter of 2020, down from EUR145 million a year prior. Swings to pretax profit of EUR19 million from EUR18 million loss. Says the full-year outlook remains uncertain, hinging on the recovery of the tourism industry. The first quarter of the year has again been a period characterised by on-going pandemic-related disruption. Despite the significant progress made both within Cyprus and globally with the vaccine roll-out programme, the day-to-day operating environment continues to be challenging, and the first quarter saw restrictions remaining in place within Cyprus. As such, our priority during the period has c
COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED: Trellus Health is commercialising the provision of digital chronic condition management solutions for employers and health plans that utilise the scientifically validated GRITT™ resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate™ to coordinate and deliver care remotely via telemedicine. The Company is initially focused on Inflammatory Bowel Diseases (IBD), which include the chronic incurable conditions of Crohn s Disease and ulcerative colitis, but considers its approach to have potential utility and demand across many chronic conditions.